TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A systematic review and meta-analysis linked ADHD with higher all-cause mortality and higher risks of suicide, injury and natural-cause death. ADHD medication use was associated with lower all-cause mortality, but that finding drew on just three studies and may be affected by confounding.
A systematic review and meta-analysis covering 19 studies and 15,920,970 participants found that ADHD was associated with a 71% higher risk of death from any cause than in comparison groups. The researchers also reported higher risks of suicide, injury and natural-cause mortality, while an association between ADHD medication use and lower mortality was based on only three studies and cannot establish that medication caused the difference.
The analysis, led by Joshua Stott of University College London and published in JAMA Network Open, estimated an all-cause mortality hazard ratio of 1.71 for people with ADHD (95% confidence interval 1.31 to 2.24). The researchers reported higher risks of suicide (HR 1.89), intentional or unintentional injury (HR 1.55), and natural-cause mortality (HR 1.27). These are comparisons across study groups, not predictions about any one person’s lifespan.
For people with ADHD who used medication, the pooled estimate indicated a 25% lower all-cause mortality risk than the comparison group used in those studies (HR 0.75, 95% CI 0.64 to 0.87). The authors cautioned that this result relied on only three studies. Differences between treated and untreated people — including healthcare access, illness severity, socioeconomic circumstances, treatment adherence and other psychiatric conditions — could affect the association.
The review included quantitative research across age groups and accepted ADHD identification through diagnostic criteria, self-identification, trait measures or genetic risk scores. Twelve of the studies contributed data to the meta-analyses. Most participants were male, and the analyses of all-cause death, suicide and injury showed substantial variation across studies, limiting how precisely the pooled estimates can be applied to different populations.
Implications for ADHD Care
The findings add to evidence that ADHD is associated with health risks extending beyond symptoms and day-to-day functioning. The elevated estimates for injury, suicide and natural causes point to several possible routes behind the overall difference, rather than one established mechanism. The study does not show that ADHD itself directly caused the deaths.
Stott and colleagues said the results support access to accurate diagnosis and care. That may be relevant for adults whose ADHD has not been recognized, but the review did not test whether expanding screening or treatment would reduce mortality. The medication result is a possible signal for further study, not proof of a protective effect or a basis for individual treatment decisions.
As an affiliate, we earn on qualifying purchases.
How Researchers Built the Review
The team reviewed quantitative studies reporting all-cause or cause-specific mortality among people identified as having ADHD. The search included peer-reviewed research available through July 2025. In total, 19 studies met the review’s criteria, while nine contributed to the all-cause mortality analysis, five to suicide, four to injury, three to natural-cause mortality and three to the medication analysis.
The report builds on earlier research that also found elevated mortality among people with ADHD. The authors noted that studies differed in populations and methods, including how ADHD was identified and access to diagnosis and care. That variation was substantial in several of the pooled analyses. The review also included cross-cultural studies and acknowledged gender imbalances, factors that may affect how well the estimates represent particular groups.
“These findings do not suggest that everyone with ADHD will die young, nor do they suggest that increased mortality is impossible to change or inherent to ADHD.”
— Joshua Stott, PhD, University College London, speaking to MedPage Today
As an affiliate, we earn on qualifying purchases.
Limits of the Mortality Estimates
The review establishes associations, not cause and effect. It cannot determine from these results whether ADHD directly raises mortality risk, how much any individual factor contributes, or whether treatment changes that risk. The medication analysis is especially limited: three studies are not enough to rule out differences between people who receive medication and those who do not.
The pooled estimates also combine studies with different methods and populations. The authors reported substantial heterogeneity in the first four analyses, meaning the size of the associations varied across studies, even though each study pointed in the same direction for mortality in ADHD groups. How the results apply to specific ages, genders, countries or diagnostic approaches remains uncertain.
As an affiliate, we earn on qualifying purchases.
Further Evidence on Treatment and Risk
The report does not announce a new clinical trial or specify a next research milestone. Its results identify areas for further investigation, particularly whether the association between ADHD medication and lower mortality persists when researchers can account more fully for differences in health, care access and treatment selection. Larger and more comparable studies could also clarify variation across age groups and populations.
For now, the study authors call attention to access to accurate ADHD diagnosis and treatment, while stressing that the findings do not mean everyone with ADHD will die young. Decisions about evaluation or treatment should be discussed with a qualified healthcare professional; this population-level analysis does not provide individual medical guidance.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the review find about ADHD and mortality?
It found that ADHD was associated with higher all-cause mortality and higher pooled estimates for suicide, injury and natural-cause mortality. The results compare groups and do not predict an individual’s outcome.
Does the study show that ADHD causes earlier death?
No. The review combined observational evidence and found associations; it does not establish that ADHD directly caused the higher mortality estimates.
Did ADHD medication lower the risk of death?
Medication use was associated with lower all-cause mortality in an analysis of three studies. The authors warned that differences between treated and untreated people could explain some or all of that association, so it does not prove medication reduces mortality.
How many people were included?
The review included 19 studies with 15,920,970 participants. Twelve studies supplied results for the meta-analyses, and the number contributing varied by outcome.
What remains uncertain?
Researchers do not yet know what share of the association reflects ADHD itself, related health or social factors, differences in diagnosis and care, or other influences. The medication finding and the applicability of pooled results to particular populations also need more evidence.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
